Evidence map›Paper›PMID 24932595›Full record

ReviewParasitology2014

Tools for diagnosis, monitoring and screening of Schistosoma infections utilizing lateral-flow based assays and upconverting phosphor labels.

Paul L A M Corstjens, Claudia J De Dood, Dieuwke Kornelis, Elisa M Tjon Kon Fat, R Alan Wilson, Thomas M Kariuki, Ruth K Nyakundi, Philip T Loverde, William R Abrams, Hans J Tanke and 3 more

Open access · greenAbstract readReview
In one paragraph

Review in Parasitology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 126 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
126citing papers in PubMed, 2 pooled it
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

126 citing papers in PubMed, 2 syntheses or guidelines pooled it, 196 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Pre-vaccinationFrontiers in immunology · 2024
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Refining Diagnosis ofFrontiers in immunology · 2018
    Trial
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

66 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Paul L A M CorstjensDepartment of Molecular Cell Biology,Leiden University Medical Center,Leiden,the Netherlands.
Claudia J De DoodDepartment of Molecular Cell Biology,Leiden University Medical Center,Leiden,the Netherlands.
Dieuwke KornelisDepartment of Parasitology,Leiden University Medical Center,Leiden,the Netherlands.
Elisa M Tjon Kon FatDepartment of Molecular Cell Biology,Leiden University Medical Center,Leiden,the Netherlands.
R Alan WilsonDepartment of Biology,University of York,York,UK.
Thomas M KariukiInstitute of Primate Research,National Museums of Kenya, Nairobi,Kenya.
Ruth K NyakundiInstitute of Primate Research,National Museums of Kenya, Nairobi,Kenya.
Philip T LoverdeDepartments of Biochemistry and Pathology,University of Texas Health Science Center,San Antonio, TX,USA.
William R AbramsDepartment of Basic Science,NYU College of Dentistry,New York, NY,USA.
Hans J TankeDepartment of Molecular Cell Biology,Leiden University Medical Center,Leiden,the Netherlands.
Lisette Van LieshoutDepartment of Parasitology,Leiden University Medical Center,Leiden,the Netherlands.
André M DeelderDepartment of Parasitology,Leiden University Medical Center,Leiden,the Netherlands.
Govert J Van DamDepartment of Parasitology,Leiden University Medical Center,Leiden,the Netherlands.
Leiden University Medical Center · NLNew York University · USUniversity of York · GB

Funding

TOWARD A MOLECULARLY-DEFINED VACCINE FOR SCHISTOSOMIASISR01AI018867 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI LOVERDE, PHILIP T · 1989 to 2009
$2.7M
TOWARD A MOLECULARLY-DEFINED VACCINE FOR SCHISTOSOMIASISR22AI018867 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI LOVERDE, PHILIP T · 1985 to 1991
–
NIAID NIH HHS AI18867NIAID NIH HHS R01 AI018867
6 · The paper itself

Abstract

The potential of various quantitative lateral flow (LF) based assays utilizing up-converting phosphor (UCP) reporters for the diagnosis of schistosomiasis is reviewed including recent developments. Active infections are demonstrated by screening for the presence of regurgitated worm antigens (genus specific polysaccharides), whereas anti-Schistosoma antibodies may indicate ongoing as well as past infections. The circulating anodic antigen (CAA) in serum or urine (and potentially also saliva) is identified as the marker that may allow detection of single-worm infections. Quantitation of antigen levels is a reliable method to study effects of drug administration, worm burden and anti-fecundity mechanisms. Moreover, the ratio of CAA and circulating cathodic antigen (CCA) is postulated to facilitate identification of either Schistosoma mansoni or Schistosoma haematobium infections. The UCP-LF assays allow simultaneous detection of multiple targets on a single strip, a valuable feature for antibody detection assays. Although antibody detection in endemic regions is not a useful tool to diagnose active infections, it gains potential when the ratio of different classes of antibody specific for the parasite/disease can be determined. The UCP-LF antibody assay format allows this type of multiplexing, including testing a linear array of up to 20 different targets. Multiple test spots would allow detection of specific antibodies, e.g. against different Schistosoma species or other pathogens as soil-transmitted helminths. Concluding, the different UCP-LF based assays for diagnosis of schistosomiasis provide a collection of tests with relatively low complexity and high sensitivity, covering the full range of diagnostics needed in control programmes for mapping, screening and monitoring.

Indexed as

Host-Parasite InteractionsAnimalsAntibodies, HelminthAntigens, HelminthEnzyme-Linked Immunosorbent AssayFecesGlycoproteinsHelminth ProteinsHumansParasite Egg CountPoint-of-Care SystemsPolysaccharidesSchistosomaSchistosomiasisSensitivity and SpecificitySpecies SpecificityAntibodies, HelminthAntigens, Helminthcirculating anodic antigen, Schistosoma mansoniGlycoproteinsHelminth ProteinsPolysaccharides

Identifiers

PMID24932595
PMCPMC4265670
OpenAlexW2103885638

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.